Excellent and important question!
I'm not familiar with LBT Innovations so I can't compare Resapp's business model or product directly. But our Resapp team have been very proactive in forging strong relationships with key potential clients and influencers in our target markets:
- The research partners in the US who have been working with us on the FDA trials.
- A German hospital chain who have commenced a pilot project for deploying ResappDx across their sites.
- Regulatory authorities around the world.
- Medecins sans frontieres intend to trial the product once it's field-ready for their operating context.
And because the product is software, free of any custom-built hardware, it can be rapidly deployed anywhere in the world without the need for physical supply logistics.
Excellent and important question!I'm not familiar with LBT...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #